Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
ACS Applied Materials & Interfaces
|
March 15, 2023
Crystalline-Amorphous Interface Coupling of Ni<sub>3</sub>S<sub>2</sub>/NiP<i></i>/NF with Enhanced Activity and Stability for Electrocatalytic Oxygen Evolution
Xinyu Wang, Xu Yu, Shuang Wu, et al.
Plos One
|
May 14, 2025
Comprehensive analysis and experiment validation of five cuproptosis-related genes in prognosis, immune infiltration and metabolic characterization of pancreatic cancer
Qianxi Deng, Kun Yang, Qiaoling Liao, et al.
The Lancet. Diabetes & Endocrinology
|
May 2, 2024
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
Christian L Roth, Cecilia Scimia, Ashley H Shoemaker, et al.
The Pediatric Infectious Disease Journal
|
August 30, 2008
Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine
Max Ciarlet, Ramei Sani-Grosso, Guojun Yuan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 12, 2015
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
Joseph Solomkin, Ellie Hershberger, Benjamin Miller, et al.
The Pediatric Infectious Disease Journal
|
February 12, 2009
Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity
Max Ciarlet, Su He, Sherry Lai, et al.
The Lancet. Diabetes & Endocrinology
|
November 10, 2022
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Andrea M Haqq, Wendy K Chung, Hélène Dollfus, et al.
The Lancet. Diabetes & Endocrinology
|
November 2, 2020
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clément, Erica van den Akker, Jesús Argente, et al.
The New England Journal of Medicine
|
July 8, 2026
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity
Jennifer L Miller, Hanneke M van Santen, Susan A Phillips, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
ACS Applied Materials & Interfaces
|
March 15, 2023
Crystalline-Amorphous Interface Coupling of Ni<sub>3</sub>S<sub>2</sub>/NiP<i></i>/NF with Enhanced Activity and Stability for Electrocatalytic Oxygen Evolution
Xinyu Wang, Xu Yu, Shuang Wu, et al.
Plos One
|
May 14, 2025
Comprehensive analysis and experiment validation of five cuproptosis-related genes in prognosis, immune infiltration and metabolic characterization of pancreatic cancer
Qianxi Deng, Kun Yang, Qiaoling Liao, et al.
The Lancet. Diabetes & Endocrinology
|
May 2, 2024
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
Christian L Roth, Cecilia Scimia, Ashley H Shoemaker, et al.
The Pediatric Infectious Disease Journal
|
August 30, 2008
Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine
Max Ciarlet, Ramei Sani-Grosso, Guojun Yuan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 12, 2015
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
Joseph Solomkin, Ellie Hershberger, Benjamin Miller, et al.
The Pediatric Infectious Disease Journal
|
February 12, 2009
Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity
Max Ciarlet, Su He, Sherry Lai, et al.
The Lancet. Diabetes & Endocrinology
|
November 10, 2022
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Andrea M Haqq, Wendy K Chung, Hélène Dollfus, et al.
The Lancet. Diabetes & Endocrinology
|
November 2, 2020
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
Karine Clément, Erica van den Akker, Jesús Argente, et al.
The New England Journal of Medicine
|
July 8, 2026
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity
Jennifer L Miller, Hanneke M van Santen, Susan A Phillips, et al.
Page
of 2